-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Satsuma Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q1 2023.
- Satsuma Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending March 31, 2023 was -$10.8M, a 30.7% increase year-over-year.
- Satsuma Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$66.2M, a 17.6% decline year-over-year.
- Satsuma Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$70.9M, a 38.7% decline from 2021.
- Satsuma Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$51.2M, a 5.87% decline from 2020.
- Satsuma Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$48.3M, a 67.3% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)